News
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...
With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results